Table 4. Changes in physical activity level, anthropometric-, metabolic characteristics and health related quality of life over the study period of 5 years a.
| A | ||||||
| TotalMET | BMI | WC | SBP | DBP | FPG | |
| β (S.E) | β (S.E) | β (S.E) | β (S.E) | β (S.E) | β (S.E) | |
| Fixed Effects | ||||||
| Level | 6.93*** (0.08) | 31.20*** (0.42) | 105.65*** (1.07) | 136.74*** (1.36) | 83.26*** (0.71) | 1.78*** (0.02) |
| Group (> 150 HCC ref.) | ||||||
| < 150 PT | -0.45*** (0.13) | 1.25 (0.67) | 3.48* (1.72) | -0.06 (2.10) | -0.31 (1.14) | 0.02 (0.03) |
| < 150 HCC | -0.46*** (0.13) | 1.31 (0.68) | 4.14* (1.76) | 1.34 (2.23) | -1.23 (1.16) | 0.03 (0.03) |
| Rate of change | 0.39*** (0.07) | -0.59*** (0.13) | -2.01*** (0.38) | -3.35*** (0.92) | -0.52** (0.18) | -0.02** (0.01) |
| Group (> 150 HCC ref.) | ||||||
| < 150 PT | -0.09 (0.12) | 0.31 (0.21) | 0.81 (0.60) | 0.06 (1.48) | -0.17 (0.29) | 0.01 (0.01) |
| < 150 HCC | -0.07 (0.02) | 0.16 (0.21) | 0.25 (0.62) | -0.66 (1.51) | 0.39 (0.30) | 0.01 (0.01) |
| Change in rate of change | -0.07*** (0.02) | 0.12*** (0.03) | 0.38*** (0.08) | 0.60*** (0.18) | - | - |
| Group (> 150 HCC ref.) | ||||||
| < 150 PT | 0.03 (0.02) | -0.09* (0.05) | -0.22 (0.13) | -0.17 (0.29) | - | - |
| < 150 HCC | 0.02 (0.02) | -0.04 (0.05) | -0.01 (0.14) | 0.08 (0.30) | - | - |
| Random Effects | ||||||
| Level | 0.26** (0.08) | 25.44*** (2.05) | 166.14*** (13.69) | 188.07*** (20.63) | 50.72*** (6.00) | 0.04*** (0.01) |
| Rate of change | 0.06 (0.07) | 0.91*** (0.21) | 7.23*** (1.76) | 23.71* (10.91) | 1.08** (0.37) | 0.01* (0.01) |
| Change in rate of change | 0.01 (0.01) | 0.06*** (0.05) | 0.35*** (0.08) | 0.67 (0.41) | - | - |
| Residuals | 0.62*** (0.04) | 1.68*** (0.09) | 14.60*** (0.77) | 118.06*** (5.99) | 47.08*** (2.06) | 0.03*** (0.01) |
| B | ||||||
| TG | Chol | HDL | LDL | PCS | MCS | |
| β (S.E) | β (S.E) | β (S.E) | β (S.E) | β (S.E) | β (S.E) | |
| Fixed Effects | ||||||
| Level | 0.34*** (0.04) | 5.57*** (0.10) | 1.42*** (0.04) | 3.59*** (0.09) | 46.75*** (0.80) | 46.17*** (0.96) |
| Group (> 150 HCC ref.) | ||||||
| < 150 PT | 0.03 (0.06) | -0.01 (0.16) | -0.02 (0.06) | 0.02 (0.13) | -2.14 (1.27) | -3.29* (1.53) |
| < 150 HCC | 0.15* (0.06) | -0.13 (0.16) | -0.09 (0.06) | -0.09 (0.14) | -0.45 (1.30) | -1.16 (1.56) |
| Rate of change | -0.05* (0.02) | -0.17** (0.06) | 0.05*** (0.02) | 0.02 (0.02) | 0.84 (0.52) | 0.80** (0.22) |
| Group (> 150 HCC ref.) | ||||||
| < 150 PT | 0.02 (0.03) | 0.05 (0.09) | 0.01 (0.03) | -0.03 (0.04) | 0.07 (0.82) | -0.21 (0.35) |
| < 150 HCC | -0.01 (0.03) | 0.04 (0.09) | 0.01 (0.03) | -0.03 (0.04) | -0.62 (0.85) | -0.21 (0.36) |
| Change in rate of change | 0.01* (0.01) | 0.02* (0.01) | -0.01** (0.01) | - | -0.30** (0.11) | - |
| Group (> 150 HCC ref.) | ||||||
| < 150 PT | -0.01 (0.01) | -0.01 (0.02) | 0.01 (0.01) | - | 0.11 (0.17) | - |
| < 150 HCC | -0.01 (0.01) | -0.01 (0.02) | -0.01 (0.01) | - | 0.17 (0.17) | - |
| Random Effects | ||||||
| Level | 0.17*** (0.02) | 1.09*** (0.12) | 0.16*** (0.01) | 0.69*** (0.09) | 64.54*** (7.60) | 104.17*** (10.79) |
| Rate of change | 0.01 (0.01) | 0.09* (0.04) | 0.01*** (0.01) | 0.02** (0.01) | 4.62 (3.41) | 1.76*** (0.52) |
| Change in rate of change | 0.01 (0.01) | 0.01 (0.01) | - | - | 0.18 (0.13) | - |
| Residuals | 0.07*** (0.01) | 0.45*** (0.02) | 0.04*** (0.01) | 0.63*** (0.03) | 35.89*** (1.96) | 58.22*** (2.69) |
MET, metabolic equivalent (minutes/week); BMI, body mass index (kg/m2); WC, waist circumference (cm); SBP, systolic blood pressure (mm/Hg); DBP, diastolic blood pressure (mm/Hg); FPG, fasting plasma glucose (mmol/L); TG, triglycerides (mmol/L); Chol, cholesterol (mmol/L); HDL, high-density lipoprotein (mmol/L); LDL, low-density lipoprotein (mmol/L); PCS, physical component summary (score); MCS, mental component summary (score).
a Univariate latent growth curve models were used as statistical method, separately for each of the measurement. Statistical significance was set at p ≤ .05: *p < .05, ** p < .01, *** p < .001.